Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06384404 · ClinicalTrials.gov registry record
Upfront Surgical Resection for Osteosarcoma
A clinical trial of Osteosarcoma, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT06384404 is a study of Osteosarcoma that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 10 participants, below the 302-participant average among 46 other Osteosarcoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06384404, a study of Osteosarcoma, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to learn about patients with newly diagnosed osteosarcoma of an extremity, and whether surgically removing the tumor prior to the administration of any chemotherapy will improve functional outcomes. In order to learn about the patient's experience, the study team will administer questionnaires to the patient and surgeon at various timepoints to assess recovery and the function of the extremity.
Conditions Studied
Interventions
- OTHER Questionnaire
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06384404
The ClinicalTrials.gov registry entry for NCT06384404 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 46 other Osteosarcoma trials with a reported enrollment target (97% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteosarcoma appearing as the primary indexed condition, and to 1 intervention - of which Questionnaire is the first listed.
NCT06384404 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06384404 about?
NCT06384404 is a clinical study titled "Upfront Surgical Resection for Osteosarcoma". The goal of this pilot study is to learn about patients with newly diagnosed osteosarcoma of an extremity, and whether surgically removing the tumor prior to the administration of any chemotherapy will improve functional outcomes. In order to learn about the patient's experience, the study team will...
What is the current status of trial NCT06384404?
This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2024-03-25. Estimated completion is 2028-12.
What conditions does trial NCT06384404 study?
This clinical trial studies the following conditions: Osteosarcoma.
What interventions are being tested in trial NCT06384404?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT06384404?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06384404 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteosarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RECRUITING · Phase 1
-
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
RECRUITING · Phase 1
-
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
RECRUITING · Phase 1
-
Losartan + Sunitinib in Treatment of Osteosarcoma
RECRUITING · Phase 1
-
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RECRUITING · Phase 3
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.